Jian Feng Shi
Amministratore Delegato presso Zhuhai Shengmei Biological Diagnostic Technology Co., Ltd.
Profilo
Jian Feng Shi is currently the Chief Executive Officer at Zhuhai Shengmei Biological Diagnostic Technology Co., Ltd.
Previously, he worked as a Director at Zhuhai Livzon Diagnostics, Inc.
Posizioni attive di Jian Feng Shi
Società | Posizione | Inizio |
---|---|---|
Zhuhai Shengmei Biological Diagnostic Technology Co., Ltd.
Zhuhai Shengmei Biological Diagnostic Technology Co., Ltd. Medical SpecialtiesHealth Technology Zhuhai Shengmei Biological Diagnostic Technology Co. Ltd. is a company that manufactures tumor liquid biopsy technology products. The company is based in Zhuhai, China. The Chinese company was founded in 2016. | Amministratore Delegato | - |
Precedenti posizioni note di Jian Feng Shi
Società | Posizione | Fine |
---|---|---|
Zhuhai Livzon Diagnostics, Inc.
Zhuhai Livzon Diagnostics, Inc. Medical SpecialtiesHealth Technology Zhuhai Livzon Diagnostics, Inc. engages in the development, production, and marketing of in-vitro diagnostic (IVD) products. Its products include diagnostic kit for Immunoglobulin M (IgM) / Immunoglobulin G (IgG) antibody to coronavirus (SARS-CoV-2), autoimmunity multiple detection platform, chemiluminescence detection platform, nucleic acid molecule detection platform, and X-ray blood irradiator. The company was founded on January 26, 1989 and is headquartered in Zhuhai, China. | Direttore/Membro del Consiglio | 13/12/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Zhuhai Livzon Diagnostics, Inc.
Zhuhai Livzon Diagnostics, Inc. Medical SpecialtiesHealth Technology Zhuhai Livzon Diagnostics, Inc. engages in the development, production, and marketing of in-vitro diagnostic (IVD) products. Its products include diagnostic kit for Immunoglobulin M (IgM) / Immunoglobulin G (IgG) antibody to coronavirus (SARS-CoV-2), autoimmunity multiple detection platform, chemiluminescence detection platform, nucleic acid molecule detection platform, and X-ray blood irradiator. The company was founded on January 26, 1989 and is headquartered in Zhuhai, China. | Health Technology |
Zhuhai Shengmei Biological Diagnostic Technology Co., Ltd.
Zhuhai Shengmei Biological Diagnostic Technology Co., Ltd. Medical SpecialtiesHealth Technology Zhuhai Shengmei Biological Diagnostic Technology Co. Ltd. is a company that manufactures tumor liquid biopsy technology products. The company is based in Zhuhai, China. The Chinese company was founded in 2016. | Health Technology |
- Borsa valori
- Insiders
- Jian Feng Shi